American alternative-investment asset manager, NYSE-listed (OWL)
Companies like Kalshi are expanding prediction markets to biotech trials, linking drug trial outcomes to tradable contracts. Bloomberg and The Guardian report Kalshi’s pilot, its safeguards, and regulatory concerns, as markets push for open data on trial probabilities amid regulatory decisions.
Oracle has issued a force majeure notice to Blue Owl Capital related to Project Jupiter, delaying payments if the data center misses its 2028 online target. Oracle says the project remains on schedule, while investors weigh the potential impact on cloud capacity and revenue.
The Securities and Exchange Commission has unveiled proposals to ease access to private markets for individual investors. Measures include opening accredited-investor status to more licenses and potentially requiring an exam. The rules aim to diversify investor participation, allow fee structures like performance fees on private assets, and expand vehicle types for private-market exposure. The proposals come as regulators push to democratize private investments while seeking guardrails against fraud.